Improving patient self-management of multiple sclerosis through a disease therapy management program.

Abstract

An MS DTM program incorporating medication management resulted in increased adherence and persistence to injectable MS medications and decreased MS relapses. Quality of life and work productivity were not significantly changed. Patients reported improved ability to manage their health.